Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Dow Jones Medical Giant Johnson & Johnson Eyes Latest Buy Point
As the Dow Jones Industrial Average and other stock indexes traded off their lows during Tuesday’s session, Johnson & Johnson (JNJ), AstraZeneca (AZN), Burlington Stores (BURL) and TJX (TJX) were among the best names to watch in the currently volatile market.
With key indexes trying to rebound from heavy losses in recent sessions, however, investors using The IBD Methodology await exceptional breakouts past correct buy points, while playing defense as they watch for sell signals.
This video file cannot be played.(Error Code: 102630)
Dow Jones index component Johnson & Johnson is fighting for support at its 50-day moving average as it moves closer to a 251.71 flat-base entry, according to IBD MarketSurge chart analysis. An early buy trigger is also in play at 247.21. Shares slipped 1.1% Tuesday afternoon.
J&J stock backstory: Johnson & Johnson is a diversified medical player, making what it calls “innovative medicines” and medical products. The innovative medicines division is J&J’s biggest, projected to bring in 64% of total sales in the first quarter.
**Unsure How To Invest In Stocks In This Market? Start Here
**
Non-Dow Jones Stocks To Watch: Burlington, TJX
Two names to watch that are not part of the Dow Jones index are Burlington Stores and TJX.
Shares of Burlington Stores are falling back below a 332.20 entry in a flat base amid Tuesday’s 3.6% midday loss. Wait for a decisive retake before considering a new purchase of shares.
Burlington stock backstory: Burlington could benefit from the Iran war. Supply disruptions could increase unwanted or closeout inventory among full-price retailers. That means off-price retail chains can buy it at cheaper prices.
Bargain retailers can be defensive growth investments in a volatile and uncertain market. New Jersey-based Burlington Stores operates 1,212 off-price retail stores that generated $11.5 billion in 2025 sales.
Internet Optimizer Getting A Handle On Cracked Market — Maybe
Meanwhile, shares of TJX are just shy of their latest buy point. The flat base has a 162.68 buy point. The stock is down nearly 2% during Tuesday’s trade.
**TJX stock backstory: ** On Feb. 25, TJX beat earnings expectations for its fiscal fourth quarter. Comparable store sales grew 5% for both the fourth quarter and the full year. On March 30, management announced a 13% dividend increase and plans for $2.5 billion to $2.75 billion in stock buybacks.
The parent of T.J. Maxx, Marshalls and Home Goods chains tied the actions to confidence in sustained profitability, strong cash flow and overall business growth.
IBD Newsletters
Get exclusive IBD analysis and actionable news daily.
IBD Newsletters
Get exclusive IBD analysis and actionable news daily.
Please enter a valid email address
Please select a newsletter
Get these newsletters delivered to your inbox & more info about our products & services. Privacy Policy & Terms of Use
Thank You!
You will now receive IBD Newsletters
Something Went Wrong!
Please contact customer service
AstraZeneca Stock Eyes Latest Buy Point
Another name to watch outside the Dow Jones Industrial Average is AstraZeneca. The stock declined 1.6% Tuesday afternoon, about 5% away from a 212.71 entry in a cup base.
**AstraZeneca stock backstory: **In late March, the U.K.-based drugmaker said its chronic obstructive pulmonary disease drug succeeded in two final-phase studies.
AstraZeneca plans to present the full results at an upcoming medical conference.
Read Between The Lines To Understand This IBD 50 Stock — And What Might Come Next
Investing Tips
Investor’s Business Daily maintains its recommended stock exposure at 0% to 20% due to heavy losses in recent sessions. That means IBD readers should adjust their exposure by cutting losses short and remaining mostly in cash. They can add limited exposure by buying stocks with exceptional breakouts, but those are in short supply.
An essential resource for daily breakouts is IBD MarketSurge’s Breaking Out Today list. It shows MarketSurge Growth 250 stocks that are rising past fresh buy points. Before making any investment decisions, be sure to check current stock market conditions. Also, use IBD Stock Checkup to view ratings for the most important fundamental and technical criteria.
To get chart analysis on stocks to buy and watch, as well as high-odds buy and sell alerts, check out IBD MarketSurge, IBD Leaderboard, and IBD SwingTrader.
Best Stocks To Watch, Including A Dow Jones Index Leader
These are the best stocks to watch near buy points, including Dow leader Johnson & Johnson.
Follow Scott Lehtonen on X at @IBD_SLehtonen for top stocks to watch and the Dow Jones Industrial Average action.
YOU MAY ALSO LIKE:
Top Growth Stocks To Buy And Watch
Learn How To Time The Market With IBD’s ETF Market Strategy
Find The Best Long-Term Investments With IBD Long-Term Leaders
Check Out IBD’s New Exposure Levels To Help You Stay In Step With The Market Trend
Spot Buy Points And Sell Signals With MarketSurge Pattern Recognition